Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5700784 | European Journal of Surgical Oncology (EJSO) | 2017 | 7 Pages |
Abstract
One third of patients with resected CRCPM in routine practice receive peri-operative chemotherapy. A randomized controlled trial is warranted to evaluate whether chemotherapy following resection of CRCPM is associated with improved survival.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Karim, S. Nanji, K. Brennan, C.S. Pramesh, C.M. Booth,